The Mobility for Life Project
Because bone and joint diseases take years to develop, it’s important for researchers to study people over a long period of time.
Join the movement
We need thousands of Albertans — both with and without bone and joint conditions —to participate in a long-term research study called the Mobility for Life Project. The information collected will form one of the world’s most comprehensive musculoskeletal health databases, helping researchers identify early indicators of disease, improve diagnosis and target effective treatment.
Researchers hope to recruit more than 10,000 study participants by 2025.
Sign-up to receive an enrollment survey
Provide us with your contact information and we will send you an enrollment survey. This survey collects basic demographic information as well as information regarding your health status.
Data collected through the enrollment survey will help researchers determine if you are eligible to participate in Phase I and II of the Mobility for Life Project.
We need your consent
If you are eligible to participate in Phase I and II of the Mobility for Life Project, you will be sent a consent form to fill out and return.
Phase I
Once we receive your consent form, you will be sent links to two surveys several weeks apart. These surveys will collect identifiable information about your health status and your diet and exercise routines. Each survey will take between 30 - 60 minutes to complete.
De-identified data from these questionnaires will be entered into a secured database housed at the University of Calgary and accessible to approved researchers for ongoing studies.
Phase II
Participants who completed Phase I (and are eligible for Phase II) will be invited to participate in subsequent studies in the University of Calgary's Centre for Mobility and Joint Health (MoJo). These studies may include:
* Medical imaging (x-ray, MRI, CT scans)
* Blood collection for genetic testing
* Body measurements
* Functional tests (such as balance and strength assessments)
De-identified data from these studies will be entered into a secured database housed at the University of Calgary and accessible to approved researchers for ongoing studies. Results from individual clinical tests shared confidentially with participants.